Home/Filings/4/0001707685-26-000002
4//SEC Filing

Utter Christine Marie 4

Accession 0001707685-26-000002

CIK 0001070081other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 5:20 PM ET

Size

7.7 KB

Accession

0001707685-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
Transactions
  • Award

    Common Stock

    2026-01-02+13,25076,343 total
  • Award

    Stock Option (Right to Buy)

    2026-01-02+33,12533,125 total
    Exercise: $76.74Exp: 2036-01-01Common Stock (33,125 underlying)
Footnotes (3)
  • [F1]Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.
  • [F2]Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.
  • [F3]This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

Entity typeother

Related Parties

1
  • filerCIK 0001707685

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:20 PM ET
Size
7.7 KB